Rchr
J-GLOBAL ID：201901006238349056   Update date: Mar. 04, 2024

Hiroki Kobayashi

コバヤシ ヒロキ | Hiroki Kobayashi
Affiliation and department：
Nihon University School of Medicine Division of Nephrology, Hypertension, and Endocrinology Department of Internal Medicine

About Nihon University School of Medicine Division of Nephrology, Hypertension, and Endocrinology Department of Internal Medicine


Other affiliations (1)：
Research field  (5)： Nephrology ,  Metabolism and endocrinology ,  Medical biochemistry ,  Physiology ,  Internal medicine - General
Research keywords  (12)： Diabetic kidney disease ,  disease modeling ,  Primary aldosteronism ,  Chronic kidney disease ,  Nephrology ,  Endocrinology ,  Diabetes ,  Hypertension ,  Renal replacement therapy ,  miRNA ,  Omics ,  Gerontology
Research theme for competitive and other funds  (33)：
  • 2024 - Elucidation of the fibrosis mechanism across multiple organs focusing on novel BMP antagonistic molecules
  • 2024 - Elucidation of the fibrotic mechanism spanning multiple organs through novel BMP antagonist
  • 2024 - Elucidation of the aldosterone secretion mechanism
  • 2023 - Development of a method for predicting cardiovascular events in hemodialysis patients focusing on Neuroblastoma suppressor of tumorigenicity 1 (NBL1)
  • 2023 - Elucidation of the fibrosis mechanism across multiple organs focusing on novel BMP antagonistic molecules
Show all
Papers (82)：
  • Eiichiro Satake, Bozena Krolewski, Hiroki Kobayashi, Zaipul I. Md Dom, Joseph Ricca, Jonathan M. Wilson, Dave S. B. Hoon, Kevin L. Duffin, Marcus G. Pezzolesi, Andrzej S. Krolewski. Quantifying circulating miRNAs: Pre-analytical considerations in profiling miRNAs that predict end-stage kidney disease in diabetes. JCI insight. 2024
  • Yoshihiro Nakamura, Hiroki Kobayashi, Kunimitsu Kanai, Masanori Abe. Sudden-onset hypertension leading to the diagnosis of unilateral hydronephrosis due to ureteropelvic junction obstruction. CEN Case Reports. 2024
  • Hiroki Kobayashi, Eiichiro Satake, Yusuke Murata, Hiromasa Otsuka, Akiko Tsunemi, Masaki Azuma, Yoshihiro Nakamura, Tomoyuki Saito, Masanori Abe. Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy. Journal of Nephrology. 2023
  • Nobuteru Takao, Takashi Maruyama, Hiroki Kobayashi, Maki Kitai, Yoshinori Yoshida, Hiroyuki Takashima, Masanori Abe. Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease. International Journal of Molecular Science. 2023
  • The Effect of Aldosterone on Cardiorenal and Metabolic Systems. International Journal of Molecular Science. 2023. 24. 6. 5370
ｍore...
Books (18)：
  • You Too Can Be a Great Doctor! Diabetic Kidney Disease (DKD)
    Japan medical journal 2024
  • Practical Guidebook to Endocrine Disease Diagnosis: Insights from Experts
    Japan medical journal 2024
  • Diabetes・Endocrinology Practice
    SOSHINSHA co. 2023
  • 腎臓栄養学
    2023
  • AKI on cardiac failure
    2023
ｍore...
Lectures and oral presentations  (134)：
  • Learning from the Proteomic Approach in Patients with Diabetes: From Biomarkers to Therapeutic Targets
    (The 61st European Renal Association (ERA), invited lecture, Stockholm 2024)
  • Identification of novel biomarkers and potential therapeutic targets in Diabetic Kidney Disease through blood proteome analysis.
    (The 12th Academy of Aging and Cardiovascular-Diabetes Research, invited lecture, Tokyo 2024)
  • Development of biomarkers that comprehensively capture the pathophysiology of diabetic kidney disease
    (The 59th Annual meeting of Society for Hypertesion Related Disease Model Research, symposium 2023)
  • Neuroblastoma suppressor of tumorigenicity 1 (NBL1) is a cause of kidney damage progression in diabetic kidney disease
    (The 59th Annual meeting of Society for Hypertesion Related Disease Model Research 2023)
  • Development of Biomarkers for Early Intervention in Diabetic Nephropathy and Their Application as Therapeutic Targets
    (The 34th Annual Meeting of Japan Diabetic Nephrology Study Group, symposium 2023)
ｍore...
Professional career (2)：
  • Ph.D. (Nihon University School of Medicine)
  • M.D. (Nihon University School of Medicine)
Work history (9)：
  • 2018 - 現在 Joslin Diabetes Center, Harvard Medical School Section on Genetics & Epidemiology, Research Division Research Fellow
  • 2018 - 現在 Nihon University School of Medicine Devision of Nephrology, Hypertension and Endocrinology Research Fellow
  • 2019 - 2021 Japan Society for the Promotion of Science Overseas Research Fellowships (Japanese government-sponsored)
  • 2018 - 2019 The Harvard Catalyst Education Program, Certificate in Applied Biostatistics
  • 2017 - 2018 Tokyo Metropolitan Hiroo Hospital Department of Diabetes and Endocrinology Attending physician
Show all
Committee career (3)：
  • 2023 - 現在 日本高血圧学会 高血圧学会基礎研究推進部会 委員
  • 2022 - Japanese Society of Renal Failure Complications Councilor
  • 2021 - Guideline committee for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2021 Committee member
Awards (40)：
  • 2024 - Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists
  • 2024 - The NOVARTIS Foundation for the Promotion of Science Research grant
  • 2024 - Yamaguchi Endocrine Research Foundation Research grant
  • 2023 - Nihon University School of Medicine Ozawa Research Grant
  • 2023 - Life Science Foundation of Japan Research grant
Show all
Association Membership(s) (13)：
Japanese Society of Renal Failure Complications ,  Japan Endocrine Pathology Society ,  Japan Hormonal Starcid Society ,  European Network for the Study of Adrenal Tumours (ENS@T) ,  American Society of Nephrology ,  The Endocrine Society ,  Japan Endocrine Society ,  The Japanese Society for Dialysis Therapy ,  The Japan Diabetes Society ,  Japanese Society of Nephrology ,  The Japanese Society of Internal Medicine ,  The Japanese Society of Hypertension ,  Japan Atherosclerosis Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM